IL2 and neoplasm: Thus, the ablation of genetic NR2F6 strongly enhances the secretion of interleukin-2 (IL-2), interferon-γ (IFN-γ), and tumor necrosis factor-α (TNF-α) both at tumor sites and ex vivo, thereby promoting antitumor immunological responses.